Evaluation and Management of Short Stature in Children

Essential Historical Information

Documenting birth parameters, such as weight, length, and head circumference, helps identify intrauterine growth restriction, which suggests different etiologies than postnatal-onset short stature, according to the American Academy of Pediatrics 2, 3
Obtaining parental heights to calculate midparental height assesses genetic potential for growth, as recommended by the American College of Medical Genetics and Genomics 1
Reviewing parental childhood growth patterns and timing of puberty is crucial, as constitutional delay and familial short stature are often inherited, according to the Genetics in Medicine guidelines 4, 5

Evaluating body proportions, such as sitting height to standing height ratio, distinguishes proportionate from disproportionate short stature, as suggested by the American Academy of Pediatrics 2, 1
Documenting dysmorphic features, including facial features, limb abnormalities, and any major or minor malformations, suggests chromosomal abnormalities or recognizable syndromes, according to the Genetics in Medicine guidelines 2, 3

For proportionate short stature without dysmorphic features, bone age assessment using left wrist radiograph determines growth potential and differentiates constitutional delay from pathologic causes, as recommended by the American College of Medical Genetics and Genomics 1, 6
Basic screening labs, including complete blood count, comprehensive metabolic panel, and thyroid function tests, rule out hypothyroidism and chronic disease, according to the Praxis Medical Insights guidelines 6

Intrauterine growth restriction assessment compares birth weight, length, and head circumference to determine if short stature began prenatally, as suggested by the American Academy of Pediatrics 2, 3
Evaluating for "catch-up" growth, as healthy SGA infants typically complete catch-up growth by age 2 years, and failure to demonstrate catch-up by this age warrants genetic evaluation, according to the Genetics in Medicine guidelines 4

Growth hormone stimulation testing is indicated if there is severe growth deceleration, clinical features suggesting GH deficiency, or if bone age is significantly delayed without other explanation, as recommended by the American College of Medical Genetics and Genomics 6
Endocrine evaluation should include assessment for combined pituitary hormone deficiencies if there are suggestive clinical features, according to the Genetics in Medicine guidelines 2, 3